ANTIGEN-DEPENDENT PROGRESSION OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT)-TYPE LYMPHOMA IN THE STOMACH - EFFECTS OF ANTIMICROBIAL THERAPY ON GASTRIC MALT LYMPHOMA IN MICE
A. Enno et al., ANTIGEN-DEPENDENT PROGRESSION OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT)-TYPE LYMPHOMA IN THE STOMACH - EFFECTS OF ANTIMICROBIAL THERAPY ON GASTRIC MALT LYMPHOMA IN MICE, The American journal of pathology, 152(6), 1998, pp. 1625-1632
In humans, low-grade B-cell mucosa-associated lymphoid tissue (MALT) l
ymphomas of the stomach regress when Helicobacter pylori infection is
cured by antimicrobial therapy. Using an animal model of human gastric
MALT lymphoma, we observed the effects of Helicobacter felis eradicat
ion and the relationship between infection and disease progression. An
timicrobial therapy was given to one-half of the BALB/c mice infected
with H. felis for 20 months. Groups of antibiotic-treated and untreate
d mice were killed 2, 3, and 4 months after antimicrobial therapy (ie,
22, 23, and 24 months after infection). The numbers of mice with MALT
decreased after H. felis eradication with no lymphoid follicles seen
4 months after treatment. MALT lymphoma was present in a total of 23%
(11/48) of antibiotic-treated infected mice compared with 75% (27/36)
in untreated infected mice. These lymphomas were further graded into l
ow-, intermediate-, and high-grade lymphoma. In the untreated mice, ly
mphoma development was more advanced with 36% low-grade (13/36), 39% i
ntermediate-grade (14/36), and 6% high-grade (large B-cell) lymphoma (
2/36) whereas in the treated mice the incidence was 21% (10/48), 6% (3
/48), and 0% (0/48), respectively. These observations suggest that ant
igenic stimulation by H. felis sustained growth and progression of low
-grade MALT lymphoma and that primary high-grade gastric lymphomas can
evolve from the transformation of these tumors. Eradication of the or
ganism caused low-grade tumors to regress, with inhibition or slowing
down of lymphoma development toward high-grade lymphoma. The H. felis
mouse model of gastric MALT lymphoma presents an opportunity to addres
s the issues arising from antimicrobial treatment of these tumors in h
umans.